Chromogranin A expression in patients with hormone naïve prostate cancer predicts the development of hormone refractory disease.
Berruti A, Mosca A, Porpiglia F, Bollito E, Tucci M, Vana F, Cracco C, Torta M, Russo L, Cappia S, Saini A, Angeli A, Papotti M, Scarpa RM, Dogliotti L.
Berruti A, et al. Among authors: angeli a.
J Urol. 2007 Sep;178(3 Pt 1):838-43; quiz 1129. doi: 10.1016/j.juro.2007.05.018. Epub 2007 Jul 16.
J Urol. 2007.
PMID: 17631319